Authors: Giglione C.; Meinnel T.

Source: Expert Opinion on Therapeutic Targets, Volume 5, Number 3, 1 June 2001 , pp. 415-418(4)

Publisher: Informa Healthcare

Abstract:

Recent work has assessed the potential of peptide deformylase (PDF) as a target for broad spectrum antibacterial agents. By using a number of approaches, including proteomics, researchers at Roche have shown that the molecules they had selected in vitro were able to target PDF in vivo. However, the authors, having observed resistance occurring at a rather high frequency and on the basis of the recent discovery of a deformylase homologue in humans, suggest that PDF ‘may not be an optimal target for broad spectrum antibacterial agents’. We link these data to results published by other laboratories and conclude that PDF deserves to still be considered a valuable target for new antibiotics.

Keywords: antibiotics; deformylase; human homologue; resistance; side effects; toxicity

Document Type: Miscellaneous

Publication date: 2001-06-01

More about this publication?

• Editorial Board
• Information for Authors
• Subscribe to this Title
• Terms & Conditions
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• In this Subject: Pharmacology
• By this author: Giglione C. ;  Meinnel T.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers